Revenue
0 USD
2024 Q4 · USD
Annual consolidated revenue for 2024: about USD 0, using the latest reported figures. The previous period, 2023, was about USD 2.762K.
30736 USD
44282749 shares
0.00% · 0 shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
-313 thousand USD
2025-09-01 – 2026-08-31
0 USD
2021-06-01 – 2022-05-31
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-14.
Financial data available through: 2026-05-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
−USD 141,600
–
Current period
−USD 312,081
–
-312081 − -141600 = -170481 USD
-141600 USD · 2024-06-01 – 2025-05-31
Inspect prior input Prior source-312081 USD · 2025-06-01 – 2026-05-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Net income, Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2017 2016-06-01 – 2017-05-31 | 6220 | Unavailable | Unavailable | Unavailable | -1249446 | -864293 Derived | Source
|
| 2019 2018-06-01 – 2019-05-31 | 0 | Unavailable | Unavailable | Unavailable | -905981 | -309457 Derived | Source
|
| 2020 2019-06-01 – 2020-05-31 | 95824 | Unavailable | Unavailable | Unavailable | -1092698 | -928307 Derived | Source
|
| 2023 2022-06-01 – 2023-05-31 | 2762 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Source
|
| 2024 2023-06-01 – 2024-05-31 | 0 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Revenue | 36557 |
|
| 2017 | Revenue | 6220 |
|
| 2019 | Revenue | 0 |
|
| 2020 | Revenue | 95824 |
|
| 2023 | Revenue | 2762 |
|
| 2024 | Revenue | 0 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Year over year | No prior comparable period |
|
| 2017 | Year over year | -83% |
|
| 2019 | Year over year | No prior comparable period |
|
| 2020 | Year over year | No prior comparable period |
|
| 2023 | Year over year | No prior comparable period |
|
| 2024 | Year over year | -100% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016-05-31 | Operating margin | Not reported |
|
| 2017-05-31 | Operating margin | Not reported |
|
| 2019-05-31 | Operating margin | Not reported |
|
| 2020-05-31 | Operating margin | Not reported |
|
| 2023-05-31 | Operating margin | Not reported |
|
| 2024-05-31 | Operating margin | Not reported |
|
| 2016 | Net margin | -5,851.5% |
|
| 2017 | Net margin | -20,087.6% |
|
| 2019 | Net margin | Not reported |
|
| 2020 | Net margin | -1,140.3% |
|
| 2023-05-31 | Net margin | Not reported |
|
| 2024-05-31 | Net margin | Not reported |
|
| 2016 | Free cash flow margin | Not reported |
|
| 2017 | Free cash flow margin | -13,895.4% |
|
| 2019 | Free cash flow margin | Not reported |
|
| 2020 | Free cash flow margin | -968.8% |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Operating cash flow | Not reported | No source recorded |
| 2017 | Operating cash flow | -754059 |
|
| 2019 | Operating cash flow | -307542 |
|
| 2020 | Operating cash flow | -925844 |
|
| 2023 | Operating cash flow | -272209 |
|
| 2024 | Operating cash flow | -145898 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Free cash flow | Unavailable | No source recorded |
| 2017 | Free cash flow | -864293 |
|
| 2019 | Free cash flow | -309457 |
|
| 2020 | Free cash flow | -928307 |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Liabilities / assets | 625.3% |
|
| 2017 | Liabilities / assets | 498.1% |
|
| 2019 | Liabilities / assets | 1,030.3% |
|
| 2020 | Liabilities / assets | 1,055.1% |
|
| 2023 | Liabilities / assets | 2,409.9% |
|
| 2024 | Liabilities / assets | 1,891.9% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Current assets / current liabilities | 0.04× |
|
| 2017 | Current assets / current liabilities | 0.07× |
|
| 2019 | Current assets / current liabilities | Not reported |
|
| 2020 | Current assets / current liabilities | Not reported |
|
| 2023-05-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2024-05-31 | Current assets / current liabilities | Not reported | No source recorded |
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2017 2016-06-01 – 2017-05-31 | −USD 1.25 million Exact valueExact value: -1249446 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 754,059 Exact valueExact value: -754059 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 110,234 Exact valueExact value: 110234 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 864,293 Calculation and evidence-754059 − 110234 USD Exact free cash flow: -864293 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2018 2017-06-01 – 2018-05-31 | −USD 1.55 million Exact valueExact value: -1546798 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 449,427 Exact valueExact value: -449427 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 449,427 Calculation and evidence-449427 − 0 USD Exact free cash flow: -449427 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2019 2018-06-01 – 2019-05-31 | −USD 905,981 Exact valueExact value: -905981 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 307,542 Exact valueExact value: -307542 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1,915 Exact valueExact value: 1915 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 309,457 Calculation and evidence-307542 − 1915 USD Exact free cash flow: -309457 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2019-06-01 – 2020-05-31 | −USD 1.09 million Exact valueExact value: -1092698 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 925,844 Exact valueExact value: -925844 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2,463 Exact valueExact value: 2463 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 928,307 Calculation and evidence-925844 − 2463 USD Exact free cash flow: -928307 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2020-06-01 – 2021-05-31 | −USD 910,836 Exact valueExact value: -910836 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 560,432 Exact valueExact value: -560432 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1,574 Exact valueExact value: 1574 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 562,006 Calculation and evidence-560432 − 1574 USD Exact free cash flow: -562006 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2021-06-01 – 2022-05-31 | −USD 697,379 Exact valueExact value: -697379 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 450,591 Exact valueExact value: -450591 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 450,591 Calculation and evidence-450591 − 0 USD Exact free cash flow: -450591 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2022-06-01 – 2023-05-31 | Unavailable Not reported for this period. | −USD 272,209 Exact valueExact value: -272209 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2023-06-01 – 2024-05-31 | Unavailable Not reported for this period. | −USD 145,898 Exact valueExact value: -145898 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2024-06-01 – 2025-05-31 | Unavailable Not reported for this period. | −USD 141,600 Exact valueExact value: -141600 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2026 2025-06-01 – 2026-05-31 | Unavailable Not reported for this period. | −USD 312,081 Exact valueExact value: -312081 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
105 filings · 2,573 latest values · 2,573 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001493712, 1493712, STME, cmxc, edgar:1493712
Also known as Cell MedX Corp., Cell Medx Corp., Plandel Resources, Inc., Sports Asylum, Inc., StimCell Energetics Inc., Stimcell Energetics Inc.